mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.002 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.004 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.005 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.006 |